Scarica l'app Stockscreener
0.8644
0.86%
0.0074
Dopo l'orario di chiusura:
.88
0.0156
+1.80%
Precedente Chiudi:
$0.857
Aprire:
$0.8479
Volume 24 ore:
116.31K
Relative Volume:
0.08
Capitalizzazione di mercato:
$73.01M
Reddito:
$153.73M
Utile/perdita netta:
$-106.79M
Rapporto P/E:
-0.4856
EPS:
-1.78
Flusso di cassa netto:
$-115.93M
1 W Prestazione:
+14.22%
1M Prestazione:
+8.21%
6M Prestazione:
-57.42%
1 anno Prestazione:
-77.78%
Intervallo 1D:
$0.8392
$0.88
Intervallo di 1 settimana:
$0.76
$0.8994
Portata 52W:
$0.5231
$5.17
Sutro Biopharma Inc Stock (STRO) Company Profile
Nome
Sutro Biopharma Inc
Settore
Industria
Telefono
650-392-8412
Indirizzo
111 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA
Confronta STRO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
STRO
Sutro Biopharma Inc
|
0.8644 | 72.38M | 153.73M | -106.79M | -115.93M | -1.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
476.95 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.39 | 60.56B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.64 | 42.41B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
575.42 | 34.96B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
294.83 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Sutro Biopharma Inc Stock (STRO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-16 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2025-03-17 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2025-03-14 | Downgrade | BofA Securities | Buy → Underperform |
| 2025-03-14 | Downgrade | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2025-03-14 | Downgrade | Wedbush | Outperform → Neutral |
| 2024-05-08 | Iniziato | BofA Securities | Buy |
| 2023-11-09 | Iniziato | Deutsche Bank | Buy |
| 2023-10-06 | Iniziato | Oppenheimer | Outperform |
| 2023-03-21 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-08-18 | Ripresa | Wells Fargo | Overweight |
| 2021-06-18 | Iniziato | H.C. Wainwright | Buy |
| 2020-12-03 | Iniziato | Stifel | Buy |
| 2020-09-02 | Iniziato | Jefferies | Buy |
| 2020-07-16 | Iniziato | Wells Fargo | Overweight |
| 2020-01-13 | Iniziato | SunTrust | Buy |
| 2019-10-07 | Iniziato | BTIG Research | Buy |
| 2019-07-18 | Iniziato | Deutsche Bank | Buy |
| 2019-04-29 | Iniziato | H.C. Wainwright | Buy |
| 2018-10-22 | Iniziato | JMP Securities | Mkt Outperform |
| 2018-10-22 | Iniziato | Piper Jaffray | Overweight |
| 2018-10-22 | Iniziato | Wedbush | Outperform |
Mostra tutto
Sutro Biopharma Inc Borsa (STRO) Ultime notizie
Here's Why Sutro Biopharma (NASDAQ:STRO) Must Use Its Cash Wisely - Yahoo Finance
What analysts say about Sutro Biopharma Inc. stockFree Stock Market Return Analysis - jammulinksnews.com
What drives Sutro Biopharma Inc. stock priceExplosive capital gains - jammulinksnews.com
Sutro Biopharma Inc. Stock Analysis and ForecastPhenomenal capital appreciation - jammulinksnews.com
Sutro Biopharma partners with FDA to develop ADC reference materials - Investing.com
Sutro Biopharma Announces Research Collaboration with the FDA to Advance Regulatory Standards for Antibody Drug Conjugates - The Manila Times
FDA Selects Sutro Biopharma's Revolutionary Platform to Shape Future of Cancer Drug Development - Stock Titan
Is Sutro Biopharma Inc. a good long term investmentBreakthrough financial growth - jammulinksnews.com
what makes sutro biopharma inc. stock price move sharplyReal Time Alert Service - Newser
Why Sutro Biopharma Inc. stock attracts strong analyst attentionHigh Return Potential - Newser
How Sutro Biopharma Inc. stock performs during market volatilityMoney Making Low Risk Plans - Newser
What makes Sutro Biopharma Inc. stock price move sharplyFree Consultation - Newser
Sutro Biopharma, Inc. (NASDAQ:STRO) Receives Consensus Recommendation of “Hold” from Brokerages - Defense World
Vontobel Holding Ltd. Has $33,000 Position in Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World
Sutro Biopharma, Inc.(NasdaqGM: STRO) dropped from Russell 2000 Dynamic Index - MarketScreener
Sutro Biopharma Faces NASDAQ Non-Compliance Notice - TipRanks
Sutro Biopharma (NASDAQ:STRO) Upgraded to Overweight at Piper Sandler - Defense World
Sutro Biopharma (STRO) Receives Upgrade to Overweight by Piper S - GuruFocus
Piper Sandler Upgrades Sutro Biopharma to Overweight From Neutral, $2 Price Target - MarketScreener
Sutro Biopharma (STRO) Receives Upgrade with Promising Drug Prospects | STRO Stock News - GuruFocus
Piper Sandler upgrades Sutro Biopharma stock rating on pipeline progress By Investing.com - Investing.com Canada
Bank of America Corp DE Sells 22,894 Shares of Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World
Sutro Biopharma, Inc. (NASDAQ:STRO) Given Consensus Rating of “Hold” by Analysts - Defense World
Piper Sandler Upgrades Sutro Biopharma (STRO) to Overweight | ST - GuruFocus
Sutro Biopharma, Inc. (NASDAQ:STRO) Stock Position Decreased by Two Sigma Investments LP - Defense World
Sutro Biopharma, Inc. (NASDAQ:STRO) Shares Sold by Millennium Management LLC - Defense World
ProShare Advisors LLC Boosts Holdings in Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World
Nuveen Asset Management LLC Acquires 124,154 Shares of Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World
Sutro Biopharma names Greg Chow as new CFO - Investing.com
Sutro Biopharma (STRO) Appoints New CFO Greg Chow | STRO Stock N - GuruFocus
Sutro Biopharma names Greg Chow as new CFO By Investing.com - Investing.com Canada
Sutro Biopharma Appoints Greg Chow as Chief Financial Officer - The Manila Times
Sutro Biopharma Inc Azioni (STRO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
4.91%
0.25%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):